comparemela.com

Latest Breaking News On - Rare disease days - Page 1 : comparemela.com

Turn Biotechnologies to Present at the Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days

/PRNewswire/ Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today announced.

Pharming to present at the Guggenheim Healthcare Talks - Genomic Medicines and Rare Disease Days

LEIDEN, The Netherlands, March 30, 2023 /PRNewswire/ Pharming Group N.V. announces that Pharming s Chief Executive Officer, Sijmen de Vries, and Chief Commercial Officer, Stephen Toor, will. | March 30, 2023

Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days

CAMBRIDGE, Mass., March 29, 2023 Wave Life Sciences Ltd. , a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases,. | March 29, 2023

Silence Therapeutics plc: Silence Therapeutics to Present at Guggenheim s Genomic Medicines and Rare Disease Days

Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through precision

Ionis to present at upcoming investor conferences

CARLSBAD, Calif., March 28, 2023 /PRNewswire/ Ionis Pharmaceuticals, Inc. today announced its participation in fireside chats at the following investor conferences: . | March 28, 2023

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.